• NEWS
  • EVENTS and PRESENTATIONS
    • EEVENTS
    • PRESENTATIONS
  • FINANCIALS
    • SEC FILINGS
    • QUARTERLY REPORTS
    • FINANCIAL FUNDIMENTALS
  • ANNUAL REPORTS
  • STOCK
    • STOCK QUOTE AND CHART
    • HISTORIC PRICE LOOKUP
    • INVESTMENT CALCULATOR
    • DIVIDEND HISTORY
    • ANALYST COVERAGE
  • ESG
    • COMMUNITIES
    • INTEGRITY and COMPLIANCE
    • SUSTAINABILITY
    • HSE and REMEDIATION
    • INCLUSION and DIVERSITY
    • POLITICAL CONTRIBUTIONS
    • ESG INFORMATION
  • GOVERNANCE
    • GOVERNANCE OVERVIEW
    • ANNUAL MEETING
    • BOARD OF DIRECTORS
    • COMMITTEE COMPOSITION
    • LEADERSHIP
  • INVESTOR RESOURCES
    • EMAIL ALERTS
    • CONTACT US
    • ONLINE INVESTOR KIT
    • SHAREOWNER SERVICES
    • GLOSSERY
Cognos Therapeutics
  • ABOUT
    • MISSION
    • BOARD of DIRECTORS
    • MANAGEMENT TEAM
    • IP MANAGEMENT
    • CLINICAL ADVISORY BOARD
    • REGULATORY AND COMPLIANCE
  • CLINICAL RELEVANCE
    • FOURTH MODALITY
  • PUBLICATIONS
  • NEWS
  • SHAREHOLDER PORTAL
    • SHAREHOLDER INFORMATION
  • CONTACT
Select Page
Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq

Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq

by cognosadminteam | Jan 3, 2023 | News

3 JANUARY, 2023 Cognos Therapeutics announced it has finalized a definitive agreement with Nocturne Acquisition Corporation to take the company public on the Nasdaq Stock Exchange. LOS ANGELES, CA. It was announced today on several financial news outlets that Cognos...

Recent Posts

  • Nocturne Acquisition Engages Chardan As Capital Markets Advisor for Cognos Acquisition
  • Nocturne Acquisition Files S-4 In Advance Of Cognos’ NASDAQ Listing
  • Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq
  • Labroot’s Report Focuses on the Need To Develop Better Methods To Deliver Therapeutics to the Brain
  • Cognos Co-Founder and CIO Josh Shachar Discusses The Evolution of the Cognos Vision

Recent Comments

    Archives

    • September 2023
    • August 2023
    • January 2023
    • January 2022
    • November 2021
    • October 2021
    • February 2019
    • January 2018
    • July 2017
    • September 2016
    • March 2015

    Categories

    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Cognos Therapeutics, Inc.

    10604 S La Cienega Blvd.
    Inglewood, CA 90304
    T: 310-641-2700
    E: info@cognosthx.com

    ADDITIONAL INFO

    Privacy Policy
    Terms of Use
    • Facebook
    • X
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress